Cargando…

Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation

Graft-versus-host disease (GVHD) remains a significant potentially life-threatening complication of allogeneic hematopoietic cell transplantation (HCT). Since the discovery of the human leukocyte antigen (HLA) system over 50 years ago, significant advances have clarified the nature of HLA variation...

Descripción completa

Detalles Bibliográficos
Autor principal:	Petersdorf, Effie W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419254/ https://www.ncbi.nlm.nih.gov/pubmed/28529723 http://dx.doi.org/10.12688/f1000research.10990.1

Ejemplares similares

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation
por: Fatobene, Giancarlo, et al.
Publicado: (2019)

Graft‐Versus‐Tumor Effect in Major Histocompatibility Complex–Mismatched Mouse Liver Transplantation
por: Yu, Dongdong, et al.
Publicado: (2019)

The World Marrow Donor Association: Twenty Years of International Collaboration for the Support of Unrelated Donor and Cord Blood Hematopoietic Cell Transplantation
por: Petersdorf, Effie W.
Publicado: (2010)

The Major Histocompatibility Complex in Transplantation
por: Ayala García, Marco Antonio, et al.
Publicado: (2012)

Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones
Publicado: (1991)

Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism
por: Bertaina, Alice, et al.
Publicado: (2018)

MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation
por: Petersdorf, Effie W, et al.
Publicado: (2007)

Histocompatibility and Hematopoietic Transplantation in the Zebrafish
por: de Jong, Jill L. O., et al.
Publicado: (2012)

The Role of Major Histocompatibility Complex in Organ Transplantation- Donor Specific Anti-Major Histocompatibility Complex Antibodies Analysis Goes to the Next Stage -
por: Nakamura, Tsukasa, et al.
Publicado: (2019)

Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions
Publicado: (1993)

Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones
Publicado: (1990)

Expression Profiling of Major Histocompatibility and Natural Killer Complex Genes Reveals Candidates for Controlling Risk of Graft versus Host Disease
por: Novota, Peter, et al.
Publicado: (2011)

Major Histocompatibility Complex-B haplotype and ovarian graft response
por: Quach, Chi Cuong, et al.
Publicado: (2023)

Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
por: Choi, Sue In, et al.
Publicado: (2016)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Ultrasonographic evaluation of gastrointestinal graft‐versus‐host disease after hematopoietic stem cell transplantation
por: Nishida, Mutsumi, et al.
Publicado: (2015)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review
por: Villarreal, Cesar Daniel Villarreal, et al.
Publicado: (2016)

Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2017)

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
por: Petersdorf, Effie W., et al.
Publicado: (2023)

Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation
por: Sajulga, Ray, et al.
Publicado: (2022)

Assessment of HLA-DPB1 genetic variation using an HLA-DP tool and its implications in clinical transplantation
por: Sajulga, Ray, et al.
Publicado: (2023)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

Major Histocompatibility Complex in Osteichthyes
por: Stosik, Michał, et al.
Publicado: (2020)

Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
por: Czech, Marie, et al.
Publicado: (2022)

The role of major histocompatibility complex molecules in luteal function
por: Cannon, Matthew J, et al.
Publicado: (2003)

Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers. Role of the H-2 complex
Publicado: (1980)

Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-γ/IL-6
por: Wang, Ying
Publicado: (2021)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
por: Kim, Dongsub, et al.
Publicado: (2018)

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease
por: Pereira, Andréa Z, et al.
Publicado: (2020)

Does minor histocompatibility antigen HA‐1 disparity affect the occurrence of graft‐versus‐host disease in tunisian recipients of hematopoietic stem cells?
por: Sellami, Mohamed Hichem, et al.
Publicado: (2010)

The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
por: Zhao, Lu, et al.
Publicado: (2019)

The role of serum uric acid in the prediction of graft‐versus‐host disease in allogeneic hematopoietic stem cell transplantation
por: Ghasemi, Katayoon, et al.
Publicado: (2020)

HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome
por: Yanover, Chen, et al.
Publicado: (2011)

Renal Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: Involvement of Chronic Graft-Versus-Host Disease
por: Mii, Akiko, et al.
Publicado: (2018)

Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation
por: Alahmari, Bader, et al.
Publicado: (2018)

“Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation”
por: Cuvelier, Geoff D. E., et al.
Publicado: (2020)

Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaito, Yuta, et al.
Publicado: (2021)

The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
por: Gao, Meng-Ge, et al.
Publicado: (2021)

Influence of culturing on the survival of major histocompatibility complex- compatible and -incompatible thyroid grafts in rats
por: Bartlett, ST, et al.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_9o1n1menhumm15tfet4t1dajks